DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Michael Di Iorio, Claire Cook, Kathleen M.M. Vanni, Naomi J. Patel, Kristin M. D’Silva, Xiaoqing Fu, Jiaqi Wang, Lauren Prisco, Emily Kowalski, Alessandra Zaccardelli, Lily W. Martin, Grace Qian, Tiffany Hsu, Zachary S. Wallace, Jeffrey A. Sparks
Topics & Concepts
MedicineHydroxychloroquineInternal medicineCoronavirus disease 2019 (COVID-19)Rheumatoid arthritisTocilizumabLogistic regressionArthritisRegimenProspective cohort studySeverity of illnessDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies